FDANews
FDAnews Device Daily Bulletin

Medtronic Partners With Local Chinese Government to Develop Diabetes Treatments

Jan. 12, 2016

Medtronic has partnered with the Chengdu, China, municipal government to manufacture and deploy advanced diabetes therapies in the city.

The medical device giant will invest in a manufacturing facility for a next-generation sensor augmented pump system with the aim of providing better diabetes management.

Medtronic also will work with the local government to enable — both in the city and the broader Sichuan province — diabetic patients access to the technology.

The announcement follows Medtronic’s August 2014 notice that it would open a plant in the city for portable hemodialysis equipment. — Michael Cipriano